Matinas BioPharma Holdings (MTNB) Change in Receivables (2015 - 2017)
Matinas BioPharma Holdings (MTNB) posted quarterly Change in Receivables of -$5.0 for Q3 2017, up 99.97% quarter-over-quarter from -$15535.0 in Q1 2015.
Matinas BioPharma Holdings (MTNB) Change in Receivables (2015 - 2017) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Change in Receivables for 2 consecutive years, with -$5.0 the latest figure, recorded in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 1.25 Mn | 437,566.66 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | -5.00 |
| Sep 30, 2017 | -5.00 |
| Mar 31, 2015 | -15,535.00 |
| Mar 31, 2015 | -15,535.00 |